★[Resultados financieros recomendados]Today’s Soliton, Nichirei, Skapar J (November 4) – Stock Search



[ad_1]

* During the intensive financial results announcement period (October 23 to November 13), three “Special Financial Results Report” will be delivered every day.

1. 1. ★[Acuerdo sorpresa]Today Delivered in the breaking news <16:00>

2. ★[Resultados financieros sorpresa]today delivered in the follow-up report <18:00>

3. 3. ★[Acuerdo recomendado]Today Delivered at <20:00>

―――――――――――――――――――――――――――

[Stock Search Premium]For members, we will provide two faster “super breaking news” every day.

1. 1. ★[Resultados financieros sorpresa]Today submitted to the Super Bulletin <15:10>

2. ★[Resultados financieros sorpresa]Today delivered in Super Bulletin / Follow-up <15:40>

Please pay attention. The delivery time will be slightly different.

1) Financial results and earnings reviews announced after today’s close (November 4)

● Recommended settlement of accounts

[Soliton<3040> ]★ The current account current term has been revised up to a 43% increase, and the dividend has also been increased by 2 yen.

◆ Consolidated revenue for the fiscal year ending December 2008 has been revised upward by 44.2% from the previous forecast of 1.04 billion yen to 1.5 billion yen. It is expected to increase by 42.7% from the previous forecast of a 1.0% decrease. In the IT security business, the growth of remote desktop cloud services for telecommuting has contributed more than expected. The progress of the adoption of the main products in the “GIGA School Concept” will also contribute to the upside.

Due to the good performance, the annual dividend for this period has been revised up from the previous plan from 10 yen to 12 yen (10 yen in the previous period).

● Amazing announcement of financial results / performance review

Takahashi Wall<1994> [JQ]★ The current term is revised up by 56% and the dividend is also increased by 3 yen.

◆ Consolidated revenue for the fiscal year ending December 2008 has been revised up by 55.6% from the previous forecast of 450 million yen to 700 million yen. The rate of decline in earnings is expected to decline from 82.7% to 73.1%. Some of the construction that was expected to be completed in the next fiscal year will be completed ahead of schedule. The significant improvement in profitability of some construction sites also boosts profits.

Due to the good performance, the annual dividend for this period has been revised up from the previous plan from 20 yen to 23 yen (30 yen in the previous period).

Nichirei<2871>★ The checking account for the current term has been revised up by 1% and the highest profit, and the dividend has also been increased by 6 yen.

◆ Consolidated revenue for the fiscal year ending March 31, 2009 has been revised up by 1.6% from the previous forecast of 31.5 billion yen to 32 billion yen. It is expected to rise 0.7% from the previous forecast for a 0.9% decline, and is expected to hit a record for the second consecutive period. In addition to the favorable performance of low temperature distribution, the cost control effect will be a positive factor.

At the same time, the annual dividend for this period has been revised up from the previous plan from 44 yen to 50 yen (42 yen in the previous period) in the form of a dividend payment commemorating the 75th anniversary of the founding.

Asuka Medicine<4514>★ First half ordinary income increased 2.2 times ・ Annual plan exceeded

◆ Consolidated revenue for the first half of the fiscal year ending March 31, 2009 (April-September) increased 2.2 times year-on-year to 1.95 billion yen and landed. Sales of the uterine fibroid treatment “Lermina” increased significantly, and the receipt of a lump sum contract from Kyorin Pharmaceutical contributed to this. The reduction in expenses due to the self-monitoring of sales activities that accompanied the spread of the new coronavirus infection also contributed to the expansion of profits.

It has already exceeded the annual plan of 1.9 billion yen and there is expected to be a fluctuation in business performance.

Fuso Medicine<4538>★ Current account for the first semester revised up 2.1 times

◆ Revenue (unconsolidated) for the first half of the fiscal year ending March 31, 2009 (April-September) has been revised 2.1 times up from the previous forecast of 750 million yen to 1.6 billion yen. The earnings growth rate is expected to increase from 19.6% to 2.6 times. Sales exceeded plan due to the sales promotion effect of generic drugs. In addition to the reduction in cost ratio, lower-than-expected sales administration costs also drove earnings.

Ebara Business<6328>★ The current term checking account was revised by 30%, the highest profit forecast added, and the dividend increased by 40 yen.

◆ Consolidated revenue for the fiscal year ending December 2008 has been revised up by 30.0% from the previous forecast of 2.27 billion yen to 2.95 billion yen. The earnings growth rate expanded from 4.7% to 36.0%, adding to the forecast of record earnings for the first time in two quarters.

Increased orders for infectious disease control products, such as negative pressure equipment, contributed to the renovation of water and sewerage facilities and disaster prevention in the water treatment department. Due to the good performance, the annual dividend for this period has been revised up from the previous plan from 60 yen to 100 yen (60 yen in the previous period).

The expected PER decreased from 12.3 times to 9.9 times, and the low-price feeling grew stronger.

Electronic reader<6867> [JQ]★ The current account for this term was reviewed 2.4 times

◆ Consolidated revenue for the first half of the fiscal year ending March 31, 2009 (April-September) fell 77.8% year-on-year to 26 million yen, but became a surplus from the forecast deficit of 100 million yen above. The contribution was the acquisition of large orders for equipment compatible with the 4K video format in North, Central and South America. Total cost reduction also contributed to the rise.

At the same time, full-year earnings have been revised up 2.4 times from the previous forecast of 35 million yen to 85 million yen. The rate of decline in benefits is expected to decline from 92.0% to 80.6%.

Skapar J<9412>★ Upward revision of current term revenue to a 3% increase

◆ Consolidated revenue for the fiscal year ending March 31, 2009 was revised up 32.0% from the previous forecast of 12.5 billion yen to 16.5 billion yen. It is expected to increase by 2.6% from the previous forecast of a 22.3% decrease. The progress of the review of the cost structure in the media business contributed. The reduction in operating costs due to the corona disaster in the space business and the postponement of some initial costs will also be positive factors.

2) The actions announced on November 5 (planned) ★ are remarkable financial results

■ Announcement during business hours

◆ Final settlement:

<7643> Daiichi [JQ]

◆ Second quarter financial results:

<1332> Nissui

<2371> Kakakucom

<2801> Kikkoman

<3861> Prince hd

<4523> Eisai ★

<8058> Mitsubishi Ratio ★

<8586> Hitachi cap

<9101> Yusen

<9107> Kawasaki Ki

<9706> Japan airport building

43 companies included

■ Announcement after closing

◆ Final settlement:

<3328> BEENOS

8 companies included

◆ First quarter financial results:

<3639> voltage

5 companies

◆ Second quarter financial results:

<1375> Snow Country Maitake

<2146> UT

<2372> Irom G

<2412> Bene One

<2784> Alfressa

<4483> JMDC [東M]

<4543> Thermos ★

<4558> Chukyo Pharmaceutical [JQ]

<4569> Kyorin

<4676> Fuji HD

<5406> Kobe Steel

<5801> Electric furukawa

<6005> Miura

<6367> Daikin

<6370> Kurita

<6845> Asville

<6869> Sysmex

<7164> National guarantee

<7269> Suzuki ★

<7606> U arrows

<7731> Nikon

<7974> Nintendo ★

<8801> Mitsui Fu ★

<9424> Japan News

<9766> Konami HD

<9831> Yamada HD

123 companies

◆ Financial results for the third quarter:

<2427> Outsourcing

<2502> Asahi ★

<3436> ★ enough

<3656> KLab

<4004> Shodenko

<4883> Modalis[東M]★

<4912> Lion

<5110> Sumitomo Go

<6326> Kubota ★

<7956> dove

<8804> East Building

19 companies included

199 companies in total

* In “Stock Search”, you can see a list of actions for[Anuncio de resultados financieros / Corrección del rendimiento]which include stock price, PER, yield, etc.

Stock Search News

[ad_2]